MeSH tree: D09.400.420
Researchers at the Texas A&M University Health Science Center (Texas A&M Health) have uncovered why C. diff (also known as Clostridioides difficile or C. difficile) infection has developed resistance to the antibiotic metronidazole.
Nov 8, 2023
0
54
New research in rodents indicates that altering gut microbes may affect the development of organ damage associated with hypertension. The findings will be presented at ASN Kidney Week 2023, November 1–5.
Nov 2, 2023
0
36
Knee and hip replacements are increasing globally due to an aging population. In the United States, the number of patients needing a joint replacement will exceed 2.7 million in the next seven years. Post-surgery infections, ...
Oct 18, 2023
0
90
Two "big gun" antibiotics thought to cause kidney failure in ICU patients with a severe bacterial infection, especially when combined with another antibiotic, may be safer for the kidneys than previously reported, following ...
Oct 16, 2023
0
48
Civica Rx, a not-for profit drug manufacturer founded by seven US health systems and three philanthropic organizations, increased supply security and lowered cost on aggregate for 20 drug products, according to the first ...
Sep 20, 2023
0
60
In a new Annals "Beyond the Guidelines" feature, an infectious diseases specialist and a gastroenterologist discuss the benefits and risks of different treatment approaches for Clostridioides difficile infection (CDI). The ...
Aug 8, 2023
0
41
A team of biochemists at the University of Notre Dame has found a possible new way to treat patients infected with Clostridioides difficile, a type of bacteria that causes serious gastrointestinal problems. In their study, ...
Researchers at NYU Grossman School of Medicine and Janssen Biotech, Inc. have shown in early tests that a bioengineered drug candidate can counter infection with Staphylococcus aureus—a bacterial species widely resistant ...
Apr 24, 2023
0
70
Researchers have developed a novel combination therapy using an anticancer agent, mitoxantrone (MTX), together with an antibiotic, vancomycin, for treating bacteria that are resistant to the vancomycin, which is also known ...
Mar 7, 2023
0
61
An experimental antibiotic is under development that is capable of neutralizing a wide range of drug-resistant, Gram-positive bacteria—pathogens that protect themselves in a slimy shield, called a biofilm, designed by nature ...
